Reconnecting patients with untreated hepatitis C to care

Relinking Diagnosed but Untreated HCV Patients Back Into Care.

Observational Universitair Ziekenhuis Brussel · NCT05975216

This study is trying to reconnect people who have been diagnosed with chronic hepatitis C but haven't received treatment to see why they stopped getting care and help them get back on track.

Quick facts

Study typeObservational
Enrollment600 (estimated)
Ages18 Years and up
SexAll
SponsorUniversitair Ziekenhuis Brussel Academic / other
Locations1 site (Brussel)
Trial IDNCT05975216 on ClinicalTrials.gov

What this trial studies

This observational study aims to reintroduce patients who have been diagnosed with chronic hepatitis C but have not received treatment back into the care pathway. It focuses on individuals who were lost to follow-up after their diagnosis between 2012 and 2022. The study will involve contacting these patients to understand the reasons for their disengagement from care and to facilitate their return to treatment.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older who have a positive HCV serology and either positive or unknown HCV RNA status.

Not a fit: Patients who have a positive HCV serology but negative HCV RNA or those who have previously eradicated the virus will not benefit from this study.

Why it matters

Potential benefit: If successful, this initiative could significantly improve treatment rates and health outcomes for patients with hepatitis C.

How similar studies have performed: While this approach is observational and focuses on re-engagement, similar studies have shown success in reconnecting patients with chronic conditions to care.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
* ≥18 years

Exclusion Criteria:

* Positive HCV serology with negative HCV RNA
* Previously eradicated patients in UZ Brussel

Where this trial is running

Brussel

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hepatitis C Virus Infection
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.